Silk route to the acceptance and re-implementation of bacteriophage therapy

Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution withPseudomonas aeruginosacystic fibrosis bacterial isolates

(2015) V-P. Friman et al.   JOURNAL OF EVOLUTIONARY BIOLOGY

Quality and Safety Requirements for Sustainable Phage Therapy Products

(2015) Jean-Paul Pirnay et al.   PHARMACEUTICAL RESEARCH

Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria

(2015) Ido Yosef et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mapping the Tail Fiber as the Receptor Binding Protein Responsible for Differential Host Specificity of Pseudomonas aeruginosa Bacteriophages PaP1 and JG004

(2013) Shuai Le et al.   PLoS One

Viral host-adaptation: insights from evolution experiments with phages

(2013) James PJ Hall et al.   Current Opinion in Virology

Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine

(2012) Gilbert Verbeken et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Diversity, stability and resilience of the human gut microbiota

(2012) Catherine A. Lozupone et al.   NATURE

Synergistic Action of Gentamicin and Bacteriophage in a Continuous Culture Population of Staphylococcus aureus

(2012) Amy E. Kirby   PLoS One

Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany

(2012) Maia Merabishvili et al.   PLoS One

Patent pools and clearinghouses in the life sciences

(2011) Esther van Zimmeren et al.   TRENDS IN BIOTECHNOLOGY

Bacteriophages as biocontrol agents of food pathogens

(2010) Jennifer Mahony et al.   CURRENT OPINION IN BIOTECHNOLOGY

Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy

(2009) T. K. Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA